View drug registration information details.
| Items | Registration information |
|---|
| ID | 1729 |
|---|
| No | 1729 |
|---|
| Brand Name | LUCIEVER |
|---|
| Ingredients | EVEROLIMUS 10 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED HORMONE RCEPTOR-POSITIVE, HER2S-NEGATIVE BREAST CANCER IN COMBINATION WITH EXEMESTANE AFTER FAILURE OF TREATMENT WITH LETREOZOLE OR ANSTROZOLE, ADULT WITH ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF TREATMENT WITH SUNITINIB OR SORAFENIB, ADULT WITH RENAL ANGIOMYOLIPOMA AND TUBERCULOSIS SCLEROSIS COMPLEX, NOT REQUIRING IMMEDIATE SURGERY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE TABLET |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 02 L 1301/25 |
|---|
| FDD Registration Date | 25-FEB-2025 |
|---|
| Expiry Date | 24-FEB-2030 |
|---|
Back to drug list
|
